Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease pheochromocytoma
Symptom C0020538|hypertension
Sentences 26
PubMedID- 20560377 hypertension due to pheochromocytoma can be masked by excessive reduction of intravascular volume by preoperative hemodialysis.
PubMedID- 23956724 hypertension due to pheochromocytoma in children tends to be more severe and refractory than in adults.
PubMedID- 24447929 Clinically, phenoxybenzamine is fda approved and currently used to treat hypertension and sweating associated with pheochromocytoma, a condition in which the adrenal glands secrete high levels of noradrenaline and adrenaline.
PubMedID- 24950401 It can be used in large doses for the short term control of hypertension in patients with phaeochromocytoma or in the treatment of hypertensive crisis following the abrupt withdrawal of clonidine.
PubMedID- 20167034 Malignant pheochromocytoma presenting with uncontrolled hypertension after kidney transplant.
PubMedID- 20930983 We have reported an unusual case of traumatic hemorrhage of occult pheochromocytoma, presenting with severe labile hypertension and associated with septic shock.
PubMedID- 24180171 The real challenge for clinicians is differentiating pheochromocytoma from other causes of hypertension (preeclampsia, gestational hypertension, and pre-existing or essential hypertension), from other cause of pulmonary edema (preeclampsia, peripartum cardiomyopathy, stress or takotsubo cardiomyopathy, pre-existing cardiac disease mitral stenosis, and high doses betamimetics), and from other causes of cardiovascular collapse (pulmonary embolism, and amniotic fluid embolism).
PubMedID- 24274233 The prevalence of pheochromocytoma in patients with hypertension, its major presenting symptom, is around 0.1%.
PubMedID- 20385503 Objective: the aim of the present study was to evaluate the relationship between adiponectin levels and insulin sensitivity in patients with endocrine hypertension due to pheochromocytoma comparing them to these in patients with essential hypertension and healthy subjects.
PubMedID- 22346144 pheochromocytoma, an uncommon cause of hypertension which has been estimated to occur in 0.1–1% of hypertensive patients,1 may be a potentially lethal disease with protean manifestations.
PubMedID- 23984157 Extreme hypertension is frequently associated with phaeochromocytoma and was evident in our patient, which as discussed previously, may have contributed to vessel rupture, increased haemorrhage and pseudoaneurysm formation.
PubMedID- 20640152 The diagnosis of pheochromocytoma was suspected in patients with poorly controlled hypertension associated with bouts of sweating, headache, palpitations, a high serum concentration of chromogranin a and a high level of metanephrins in urine.
PubMedID- 20734598 pheochromocytoma was associated with hypertension in 6 cases.
PubMedID- 26098187 Among patients with arterial hypertension the prevalence of cushing's syndrome or pheochromocytoma is less than 1%.
PubMedID- 21060667 Bilateral optic disc swelling has been reported in a child with severe hypertension due to pheochromocytoma without any other evidence of grade 4 hypertensive retinopathy.11 in the absence of other causes of papilledema and the resolution of the papilledema with control of hypertension, the papilledema was attributed to severe hypertension.
PubMedID- 21223554 The prevalence of pheochromocytoma in patients with hypertension is 0.1-0.6%, and secretes both epinephrine and norepinephrine in at least 50% of cases.
PubMedID- 23776872 In addition to the classical triad, pheochromocytoma is commonly associated with hypertension, cardiomyopathy, myocardial infarction, and cerebrovascular accident.
PubMedID- 22148096 Intraoperative hypertension in a patient with undiagnosed pheochromocytoma under spinal anesthesia.
PubMedID- 22611502 With hindsight this is not a logical choice since beta-blockade can worsen hypertension in the presence of a phaeochromocytoma, by opposing beta-adrenoceptor-activated vasodilatation in skeletal muscle beds.
PubMedID- 23153989 Gestational diastolic hypertension with gene mutation-related pheochromocytoma positive at (1)(8)f-dopa pet/ct: diagnostic and therapeutic implications.
PubMedID- 24009448 All patients should undergo a hormonal evaluation for subclinical cushing syndrome and pheochromocytoma, and those with hypertension should also be evaluated for primary hyperaldosteronism.
PubMedID- 25838955 It is of significant importance to clarify that hypertension due to pheochromocytoma is paroxysmal, appearing before the 20th week of pregnancy and it may be followed by orthostatic hypotension, unlike gestational hypertension.
PubMedID- 21887038 Management of paroxysmal hypertension due to incidental pheochromocytoma in pregnancy.
PubMedID- 22584715 The first two affected individuals, i-2 and ii-3, developed huge neck lumps (presumably mtc) and severe hypertension (presumably due to pheochromocytoma), causing aphonia (presumably as a result of recurrent laryngeal nerve invasion) and hemiplegia at the age of 42 years (presumably following cathecholamine excess) in individual ii-3.
PubMedID- 21632813 All patients should undergo hormonal evaluation for subclinical cushing's syndrome and pheochromocytoma, and those with hypertension should also be evaluated for hyperaldosteronism.
PubMedID- 25140230 Introduction: the prevalence of phaeochromocytoma (pcc) in patients with hypertension is 0.1-0.6% and about 10% of pccs are detected in extra-adrenal tissue.

Page: 1